{{Rsnum
|rsid=12368653
|Gene=AGAP2
|Chromosome=12
|position=57739473
|Orientation=plus
|GMAF=0.3168
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=AGAP2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 22.1 | 45.1 | 32.7
| HCB | 1.5 | 28.5 | 70.1
| JPT | 0.0 | 18.6 | 81.4
| YRI | 4.8 | 31.3 | 63.9
| ASW | 5.3 | 38.6 | 56.1
| CHB | 1.5 | 28.5 | 70.1
| CHD | 0.9 | 25.7 | 73.4
| GIH | 12.9 | 33.7 | 53.5
| LWK | 7.3 | 45.5 | 47.3
| MEX | 6.9 | 48.3 | 44.8
| MKK | 16.1 | 57.4 | 26.5
| TSI | 24.5 | 61.8 | 13.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=19525955
|Title=Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
}}

{{omim
|id=126200
|rsnum=12368653
}}

{{PMID Auto
|PMID=20405052
|Title=The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression.
|OA=1
}}

{{PMID Auto GWAS
  |PMID=21833088
  |Trait=Multiple sclerosis
  |Title=Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
  |RiskAllele=A
  |Pval=2E-9
  |OR=1.10
  |ORtxt=[1.09-1.12]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}